Stay updated on Cetuximab + Avelumab vs. Avelumab in SCCAC Clinical Trial
Sign up to get notified when there's something new on the Cetuximab + Avelumab vs. Avelumab in SCCAC Clinical Trial page.

Latest updates to the Cetuximab + Avelumab vs. Avelumab in SCCAC Clinical Trial page
- Check2 days agoChange DetectedThe clinical trial record is displayed, describing the randomized phase 2 comparison of avelumab alone versus avelumab plus cetuximab for advanced squamous cell anal carcinoma. It includes study design, eligibility criteria, outcome measures, the Italian study location, record dates, and related publications.SummaryDifference45%

- Check9 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedA sitewide NIH notice was added about website updates and the transition from “Artificial Intelligence” to “Super Intelligence.” The site revision changed from v3.7.1 to v3.7.2.SummaryDifference1%

- Check37 days agoChange DetectedThe site’s footer revision identifier changes from v3.7.0 to v3.7.1, while the study page continues to show a 403 error.SummaryDifference0.2%

- Check51 days agoChange DetectedThe page now renders a 403 Forbidden error page instead of the study record. The new content shows a minimal header and a Home link, indicating the study details at this URL are inaccessible.SummaryDifference18%

- Check58 days agoChange DetectedThe page now displays a newer revision identifier, changing from v3.6.6 to v3.7.0. This reflects a backend/template update and does not modify the study details or content shown on the page.SummaryDifference0.1%

- Check72 days agoChange DetectedThe page's revision label was updated from v3.6.5 to v3.6.6, indicating a new revision of the study record.SummaryDifference0.1%

Stay in the know with updates to Cetuximab + Avelumab vs. Avelumab in SCCAC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cetuximab + Avelumab vs. Avelumab in SCCAC Clinical Trial page.